Granulab is committed to maintain and to improve the effectiveness of its Good Manufacturing Practice based on quality management system in compliance to ISO 13485:2016 and MDD 93/42/EEC as amended by 2007/47/EC from British Standards Institute (BSI) Netherlands.
Granulab is committed to maintainandto improve the effectiveness of its GoodDistribution Practice of Medical Devicesfor products sourced manufacturers for fromothertrading ordistributorship purposes
In 2023, Granulab has obtainedGranumas® Product Registration licensefrom the Ministry of Health Indonesia to enter Indonesian market.
In 2023, has obtained PROSTEOMAX Granulab Product Registration license from the Ministry of Health Indonesia to enter Indonesian market






